Mechanisms of protective effects induced by blockade of the renin–angiotensin system: novel role of the pancreatic islet angiotensin‐generating system in Type 2 diabetes

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Diabetic Medicine

• Publication date

  2007-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1464-5491.2007.02072.xPMID 17257271
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of ramipril on the incidence of diabetes.

  2007cited by this paper
• Angiotensin II type 1 receptor blockade improves beta-cell function and glucose tolerance in a mouse model of type 2 diabetes.

  2006cited by this paper
• Direct regulation of insulin secretion by angiotensin II in human islets of Langerhans

  2006cited by this paper
• Frontiers in diabetic research.

  2006cited by this paper
• High glucose increases extracellular matrix production in pancreatic stellate cells by activating the renin–angiotensin system

  2006cited by this paper
• The direct effects of the angiotensin-converting enzyme inhibitors, zofenoprilat and enalaprilat, on isolated human pancreatic islets.

  2006cited by this paper
• Effect of ramipril on the incidence of diabetes.

  2006cited by this paper
• AT1 receptor antagonism ameliorates acute pancreatitis-associated pulmonary injury.

  2006cited by this paper
• Beta-cell preservation: a potential role for thiazolidinediones to improve clinical care in Type 2 diabetes.

  2005cited by this paper
• Pancreatic Islet Renin Angiotensin System: Its Novel Roles in Islet Function and in Diabetes Mellitus

  2005cited by this paper
• Angiotensin II type 1 receptor inhibition markedly improves the blood perfusion, oxygen tension and first phase of glucose-stimulated insulin secretion in revascularised syngeneic mouse islet grafts

  2005cited by this paper
• Angiotensin II enhances insulin sensitivity in vitro and in vivo.

  2005cited by this paper
• Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials.

  2005cited by this paper
• Long-term treatment with losartan versus atenolol improves insulin sensitivity in hypertension: ICARUS, a LIFE substudy

  2005cited by this paper
• β‐cell preservation: a potential role for thiazolidinediones to improve clinical care in Type 2 diabetes

  2005cited by this paper
• Prophylactic and therapeutic treatments with AT 1 and AT 2 receptor antagonists and their effects on changes in the severity of pancreatitis.

  2004cited by this paper
• Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.

  2004cited by this paper
• Evidence for a local angiotensin-generating system and dose-dependent inhibition of glucose-stimulated insulin release by angiotensin II in isolated pancreatic islets

  2004cited by this paper
• Angiotensin Type 1 Receptor Blockers Induce Peroxisome Proliferator–Activated Receptor-γ Activity

  2004cited by this paper
• Improved islet morphology after blockade of the renin- angiotensin system in the ZDF rat.

  2004cited by this paper
• Immunohistochemical colocalization of type II angiotensin receptors with somatostatin in rat pancreas.

  2004cited by this paper
• Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 2. Overview of physiological and biochemical mechanisms.

  2004cited by this paper
• The role of the pancreatic renin-angiotensin system in acinar digestive enzyme secretion and in acute pancreatitis.

  2004cited by this paper
• Rationale, design and recruitment characteristics of a large, simple international trial of diabetes prevention: the DREAM trial

  2004cited by this paper
• Ramipril treatment suppresses islet fibrosis in Otsuka Long-Evans Tokushima fatty rats.

  2004cited by this paper
• The peptide hormone angiotensin II: its new functions in tissues and organs.

  2004cited by this paper
• Insulin-sensitizing effects of telmisartan: implications for treating insulin-resistant hypertension and cardiovascular disease.

  2004cited by this paper
• Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 1. A meta-analysis of randomised clinical trials.

  2004cited by this paper
• Differential effects of saralasin and ramiprilat, the inhibitors of renin-angiotensin system, on cerulein-induced acute pancreatitis.

  2003cited by this paper
• The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome?

  2003cited by this paper
• The double puzzle of diabetes

  2003cited by this paper
• Bradykinin, angiotensin-(1-7), and ACE inhibitors: how do they interact?

  2003cited by this paper
• Insulin resistance: a global epidemic in need of effective therapies

  2003cited by this paper
• Saralasin, a Nonspecific Angiotensin II Receptor Antagonist, Attenuates Oxidative Stress and Tissue Injury in Cerulein-Induced Acute Pancreatitis

  2003cited by this paper
• Changes of angiotensin-converting enzyme activity in the pancreas of chronic hypoxia and acute pancreatitis.

  2003cited by this paper
• Obesity-associated activation of angiotensin and endothelin in the cardiovascular system.

  2003cited by this paper
• Predominant role of reduced beta-cell sensitivity to glucose over insulin resistance in impaired glucose tolerance

  2003cited by this paper
• A local pancreatic renin-angiotensin system: endocrine and exocrine roles.

  2003cited by this paper
• The prevalence of obesity.

  2003cited by this paper
• Renin–angiotensin systems: the new frontier

  2003cited by this paper
• Angiotensin II Evokes Calcium-Mediated Signaling Events in Isolated Dog Pancreatic Epithelial Cells

  2002cited by this paper
• Angiotensin blockade prevents type 2 diabetes by formation of fat cells.

  2002cited by this paper
• Mature adipocytes inhibit in vitro differentiation of human preadipocytes via angiotensin type 1 receptors.

  2002cited by this paper
• Diabetes and atherosclerosis: epidemiology, pathophysiology, and management.

  2002cited by this paper
• Angiotensin II and growth factors in the pathogenesis of diabetic nephropathy.

  2002cited by this paper
• Global and societal implications of the diabetes epidemic

  2001cited by this paper
• Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.

  2001cited by this paper
• Tissue renin-angiotensin system: its expression, localization, regulation and potential role in the pancreas.

  2001cited by this paper
• Local blood flow regulation in transplanted rat pancreatic islets: influence of adenosine, angiotensin II, and nitric oxide inhibition.

  2000cited by this paper
• Regulated expression of pancreatic renin-angiotensin system in experimental pancreatitis.

  2000cited by this paper
• Expression and localization of the renin-angiotensin system in the rat pancreas.

  1999cited by this paper
• ACE inhibition and glucose transport in insulinresistant muscle: roles of bradykinin and nitric oxide.

  1999cited by this paper
• The tissue renin-angiotensin system in human pancreas.

  1999cited by this paper
• Angiotensin II and the endocrine pancreas: effects on islet blood flow and insulin secretion in rats

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Evidence that nitric oxide increases glucose transport in skeletal muscle.

  1997cited by this paper
• Localization of angiotensin II receptor subtypes AT1 and AT2 in the pancreas of rodents.

  1997cited by this paper
• Phenotypes of Mouse diabetes and Rat fatty Due to Mutations in the OB (Leptin) Receptor

  1996cited by this paper
• Prevalence of obesity.

  1996cited by this paper
• Insulin Sensitivity in Obese Hypertensive Dyslipidemic Patients Treated with Enalapril or Atenolol

  1995cited by this paper
• Kinins contribute to the improvement of insulin sensitivity during treatment with angiotensin converting enzyme inhibitor.

  1994cited by this paper
• OLETF (Otsuka Long-Evans Tokushima Fatty) rat: a new NIDDM rat strain.

  1994cited by this paper
• A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension.

  1989cited by this paper
• Plasma beta-thromboglobulin in patients with valvular heart disease with or without valve replacement: relationship with thromboembolic accidents.

  1984cited by this paper
• The life story of the pancreatic B cell

  1984cited by this paper
• Printed in U.S.A. Copyright © 2003 by The Endocrine Society doi: 10.1210/en.2003-0150 Minireview: Overview of the Renin-Angiotensin System—

  year unknowncited by this paper

• Metabolic and Vascular Insulin Resistance: Partners in the Pathogenesis of Cardiovascular Disease in Diabetes.

  2025cites this paper
• Rescuing vascular dysfunction in dorsal pancreatic arteries prevents tacrolimus-induced glucose metabolism disorder in mice

  2025cites this paper
• EGCG-derived polymeric oxidation products enhance insulin sensitivity in db/db mice

  2022cites this paper
• Angiotensin(1-7) Improves Islet Function in Diabetes Through Reducing JNK/Caspase-3 Signaling.

  2022cites this paper
• Autoantibody against angiotensin II type I receptor induces pancreatic β-cell apoptosis via enhancing autophagy.

  2021cites this paper
• Diabetes and Renin-Angiotensin-Aldosterone System: Pathophysiology and Genetics

  2021cites this paper
• Chronic Intermittent Hypoxia Triggers a Senescence-like Phenotype in Human White Preadipocytes

  2020cites this paper
• Angiotensin‐converting enzyme as a new immunologic target for the new SARS‐CoV‐2

  2020cites this paper
• NLRP3 inflammasome mediates angiotensin II-induced islet β cell apoptosis.

  2019cites this paper
• Insulin Resistance and the Kidney in Youth

  2019cites this paper
• Effects of Irbesartan Pretreatment on Pancreatic β-Cell Apoptosis in STZ-Induced Acute Prediabetic Mice

  2018cites this paper
• Universitet Re-analysis of public genetic data reveals a rare X-chromosomal variant associated with type 2 diabetes

  2018cites this paper
• Pilot genome-wide association study identifying novel risk loci for type 2 diabetes in a Maya population.

  2018cites this paper
• Re-analysis of public genetic data reveals a rare X-chromosomal variant associated with type 2 diabetes

  2018cites this paper
• A comprehensive reanalysis of publicly available GWAS datasets reveals an X chromosome rare regulatory variant associated with high risk for type 2 diabetes

  2017cites this paper
• Effects of β(3)-adrenoceptor activation on expression of pancreatic adrenoceptors and angiotensin II receptors in ApoE(-/-) mice.

  2015cites this paper
• ZSF1 rat: a model of chronic cardiac and renal diseases in the context of metabolic syndrome. Characterization with anti-oxidant, mineralocorticoid receptor antagonist and aldosterone synthase inhibitor

  2015cites this paper
• Involvement of Telmisartan on the Protective Effects Mediated by the Peroxisome Proliferator-Activated Receptor-γ Pathway in Mice

  2014cites this paper
• Effects of combination therapy with vildagliptin and valsartan in a mouse model of type 2 diabetes

  2013cites this paper
• Angiotensin-Converting Enzyme 2 Deficiency Aggravates Glucose Intolerance via Impairment of Islet Microvascular Density in Mice with High-Fat Diet

  2013cites this paper
• Ang(1–7) treatment attenuates β-cell dysfunction by improving pancreatic microcirculation in a rat model of Type 2 diabetes

  2013cites this paper
• The Renin Angiotensin Aldosterone System and Insulin Resistance in Humans

  2013cites this paper
• The Regulatory Effect of Renin-Angiotensin-Aldosterone System on Insulin Secretion *

  2013cites this paper
• The effects of long-term valsartan treatment on skeletal muscle fatty acid handling in humans with impaired glucose metabolism.

  2013cites this paper
• Selective Angiotensin Type 1 Receptor Antagonists as Peroxisome Proliferator - Actived Receptor modulators

  2012cites this paper
• Angiotensin II Type 2 Receptor Is Critical for the Development of Human Fetal Pancreatic Progenitor Cells into Islet‐like Cell Clusters and Their Potential for Transplantation

  2012cites this paper
• The Renin-Angiotensin System in the Pathophysiology of Type 2 Diabetes

  2012cites this paper
• The Role of Angiotensin Converting Enzyme (ACE) 2 in a Murine Model of Insulin Resistance and Albuminuria

  2012cites this paper
• Valsartan Improves Adipose Tissue Function in Humans with Impaired Glucose Metabolism: A Randomized Placebo-Controlled Double-Blind Trial

  2012cites this paper
• Evidence of an Intracellular Angiotensin-Generating System and Non-AT1, Non-AT2 Binding Site in a Human Pancreatic Cell Line

  2011cites this paper
• Effects of whey protein supplements on metabolism: evidence from human intervention studies

  2011cites this paper
• Functional expression of angiotensinogen depends on splicing enhancers in exon 2.

  2011cites this paper
• Effects of Low Doses of Captopril or Losartan in Improving Glycemic Control by Oral Hypoglycemic Agents in Type 2 DM Patients

  2010influential citation
• Current research of the RAS in diabetes mellitus.

  2010cites this paper
• Calcitriol and the Renin Angiotensin System, and Adipose Tissue Inflammation

  2009cites this paper
• Association of hematological parameters with insulin resistance and beta-cell dysfunction in nondiabetic subjects.

  2009cites this paper
• Olmesartan and temocapril prevented the development of hyperglycemia and the deterioration of pancreatic islet morphology in Otsuka-Long-Evans-Tokushima Fatty rats.

  2009cites this paper
• Treatment of Prehypertension in Diabetes and Metabolic Syndrome

  2009cites this paper
• Angiotensin II type 1 receptor antagonists prevent glucose‐induced increases in islet blood flow in rats

  2009cites this paper
• An association between angiotensin II type 2 receptor gene A/C3123 polymorphism and glycemic control marker in a general Japanese population

  2009cites this paper
• The management of the type 2 diabetic patient with hypertension – too late and too little: Suggested improvements

  2008cites this paper
• Preserving insulin secretion in Type 2 diabetes mellitus

  2008cites this paper
• ¿Qué ha cambiado en Cardiología en el último año?: implicaciones para la práctica clínica

  2008cites this paper
• The renin–angiotensin–aldosterone system: a pivotal role in insulin sensitivity and glycemic control

  2008cites this paper
• Combination of the Dipeptidyl Peptidase IV Inhibitor LAF237 [(S)-1-[(3-Hydroxy-1-adamantyl)ammo]acetyl-2-cyanopyrrolidine] with the Angiotensin II Type 1 Receptor Antagonist Valsartan [N-(1-Oxopentyl)-N-[[2′-(1H-tetrazol-5-yl)-[1,1′-biphenyl]-4-yl]methyl]-l-valine] Enhances Pancreatic Islet Morpholo

  2008cites this paper
• Enalapril treatment corrects the reduced response to bradykinin in diabetes increasing the B2 protein expression.

  2008cites this paper
• Bibliography. Current world literature. Diabetes and the endocrine pancreas.

  2008cites this paper
• Lack of potentiation of bradykinin by angiotensin-(1-7) in a type 2 diabetes model: role of insulin.

  2007cites this paper
• An update on non-peptide angiotensin receptor antagonists and related RAAS modulators.

  2007influential citation
• Diabetes and the endocrine pancreas Acute myocardial infarction in diabetes

  year unknowncites this paper